Ashley joined Investor Growth Capital’s New York office with the Healthcare team in 2003. He focuses primarily on medical device and biopharmaceutical investments.
Prior to joining IGC, Ashley worked in the healthcare investment banking group at Lehman Brothers, where he completed various M&A, equity and debt transactions in the life science, specialty pharmaceutical and healthcare services sectors.
Ashley received his Bachelor of Science degree from Yale University in both Molecular Biology and Economics.
Ashley is currently a Board observer and/ or works closely with the following portfolio companies: Applied Spine Technologies, Axiomed Spine Corporation, Biolex Therapeutics, Cayenne Medical and CHF Solutions.